| VRTX |
Vertex Pharmaceuticals Incorporated |
128.95b |
499.39 |
(1.84%) |
28.82 |
35.00% |
10.23% |
— |
| MRNA |
Moderna, Inc. |
94.42b |
218.01 |
(7.82%) |
0.00 |
(141.43%) |
(27.62%) |
— |
| REGN |
Regeneron Pharmaceuticals, Inc. |
81.99b |
790.74 |
(0.70%) |
18.87 |
27.86% |
9.29% |
0.47% |
| ARGX |
argenex SE |
53.22b |
819.14 |
(3.21%) |
29.55 |
32.20% |
70.58% |
— |
| RVMD |
Revolution Medicines, Inc. |
40.57b |
177.96 |
(5.97%) |
0.00 |
0.00% |
(8.81%) |
— |
| ONC |
BeOne Medicines Ltd. - Sponsored ADR |
39.01b |
369.06 |
(1.34%) |
62.55 |
10.70% |
34.35% |
— |
| RPRX |
Royalty Pharma PLC |
34.28b |
60.96 |
2.80% |
42.27 |
32.02% |
10.01% |
1.51% |
| ALNY |
Alnylam Pharmaceuticals, Inc. |
31.32b |
231.83 |
(0.94%) |
39.50 |
16.13% |
95.14% |
— |
| ROIV |
Roivant Sciences Ltd. |
24.59b |
33.53 |
(1.50%) |
0.00 |
(3,534.96%) |
(67.58%) |
— |
| INCY |
Incyte Corporation |
22.96b |
112.95 |
(0.28%) |
13.89 |
27.71% |
26.93% |
— |
| BNTX |
BioNTech SE Sponsored ADR |
22.66b |
87.71 |
(2.92%) |
0.00 |
(65.75%) |
(3.33%) |
— |
| GMAB |
Genmab A/S Sponsored ADR |
22.60b |
37.00 |
(2.17%) |
29.13 |
19.08% |
22.26% |
— |
| INSM |
Insmed, Inc. |
21.67b |
96.27 |
(2.96%) |
0.00 |
(76.94%) |
185.76% |
— |
| EXEL |
Exelixis, Inc. |
15.57b |
62.11 |
(1.15%) |
18.82 |
35.33% |
9.23% |
— |
| ASND |
Ascendis Pharma A/S |
14.88b |
225.78 |
(0.37%) |
16.28 |
71.20% |
125.98% |
— |
| JAZZ |
Jazz Pharmaceuticals PLC |
13.92b |
210.23 |
(2.04%) |
13.77 |
20.45% |
12.59% |
— |
| HALO |
Halozyme Therapeutics, Inc. |
13.79b |
121.84 |
0.27% |
34.61 |
24.86% |
41.15% |
— |
| BBIO |
BridgeBio Pharma, Inc. |
13.12b |
66.39 |
(1.10%) |
0.00 |
(97.03%) |
202.39% |
— |
| SMMT |
Summit Therapeutics PLC |
12.26b |
14.63 |
(4.81%) |
0.00 |
0.00% |
(61.03%) |
— |
| CORT |
Corcept Therapeutics Incorporated |
12.26b |
110.16 |
(2.83%) |
211.85 |
6.53% |
16.02% |
— |
| TECH |
Bio-Techne Corp |
11.37b |
72.57 |
0.03% |
62.00 |
14.97% |
(0.38%) |
0.44% |
| BMRN |
BioMarin Pharmaceutical Inc. |
10.85b |
54.68 |
(2.44%) |
143.89 |
2.14% |
11.20% |
— |
| MDGL |
Madrigal Pharmaceuticals, Inc. |
10.62b |
449.74 |
(2.19%) |
0.00 |
(25.32%) |
149.04% |
— |
| IBRX |
ImmunityBio, Inc. |
10.60b |
9.18 |
(8.20%) |
0.00 |
(598.56%) |
192.92% |
— |
| PCVX |
Vaxcyte, Inc. |
10.27b |
63.62 |
(2.53%) |
0.00 |
0.00% |
— |
— |
| KRYS |
Krystal Biotech, Inc. |
9.77b |
316.58 |
(4.07%) |
38.28 |
54.82% |
22.63% |
— |
| KYMR |
Kymera Therapeutics, Inc. |
8.99b |
104.78 |
(3.11%) |
0.00 |
(285.33%) |
134.84% |
— |
| CAI |
Caris Life Sciences,�Inc. |
8.98b |
30.56 |
(3.78%) |
81.30 |
8.15% |
96.36% |
— |
| CYTK |
Cytokinetics, Incorporated |
8.89b |
61.95 |
(3.08%) |
0.00 |
(1,321.12%) |
(21.07%) |
— |
| PTGX |
Protagonist Therapeutics, Inc. |
8.84b |
128.75 |
(5.71%) |
105.53 |
29.40% |
34.81% |
— |
| TGTX |
TG Therapeutics, Inc. |
8.57b |
53.97 |
(3.63%) |
17.75 |
55.22% |
76.08% |
— |
| AXSM |
Axsome Therapeutics, Inc. |
8.47b |
157.14 |
(2.87%) |
0.00 |
(24.68%) |
56.87% |
— |
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
8.26b |
55.90 |
(4.44%) |
0.00 |
(47.79%) |
16.13% |
— |
| ABVX |
Abivax SA Sponsored ADR |
8.09b |
87.78 |
(4.98%) |
0.00 |
0.00% |
— |
— |
| SYRE |
Spyre Therapeutics, Inc. |
7.39b |
79.90 |
(0.25%) |
0.00 |
0.00% |
(81.84%) |
— |
| IONS |
Ionis Pharmaceuticals, Inc. |
7.33b |
42.94 |
(2.67%) |
0.00 |
(64.66%) |
(7.41%) |
— |
| PRAX |
Praxis Precision Medicines, Inc. |
6.93b |
241.76 |
(2.61%) |
0.00 |
0.00% |
249.53% |
— |
| IOVA |
Iovance Biotherapeutics, Inc. |
6.67b |
13.62 |
(7.74%) |
0.00 |
(89.09%) |
34.55% |
— |
| BLTE |
Belite Bio, Inc. Sponsored ADR |
6.15b |
142.78 |
(6.45%) |
0.00 |
0.00% |
— |
— |
| RYTM |
Rhythm Pharmaceuticals, Inc. |
6.06b |
86.17 |
(2.05%) |
0.00 |
(87.62%) |
53.51% |
— |
| LGND |
Ligand Pharmaceuticals Incorporated |
5.95b |
295.54 |
(0.99%) |
29.52 |
67.88% |
54.89% |
— |
| IMVT |
Immunovant, Inc. |
5.68b |
26.73 |
(2.84%) |
0.00 |
0.00% |
— |
— |
| KOD |
Kodiak Sciences Inc. |
5.54b |
85.75 |
(2.69%) |
0.00 |
0.00% |
— |
— |
| CGON |
CG Oncology, Inc. |
5.48b |
59.79 |
(3.35%) |
0.00 |
(3,602.68%) |
840.79% |
— |
| MIRM |
Mirum Pharmaceuticals, Inc. |
5.35b |
80.14 |
(2.68%) |
0.00 |
(139.18%) |
44.02% |
— |
| ERAS |
Erasca, Inc. |
5.20b |
13.39 |
(9.95%) |
0.00 |
0.00% |
— |
— |
| COGT |
Cogent Biosciences, Inc. |
5.12b |
29.52 |
0.03% |
0.00 |
0.00% |
110.23% |
— |
| PTCT |
PTC Therapeutics, Inc. |
5.09b |
59.24 |
(2.87%) |
0.00 |
(3.80%) |
(42.84%) |
— |
| CRSP |
CRISPR Therapeutics AG |
4.98b |
49.25 |
(4.31%) |
0.00 |
(3,368.72%) |
(64.80%) |
— |
| TVTX |
Travere Therapeutics, Inc. |
4.98b |
49.60 |
(6.00%) |
0.00 |
(7.35%) |
77.12% |
— |
| SRRK |
Scholar Rock Holding Corporation |
4.95b |
39.90 |
(1.94%) |
0.00 |
0.00% |
213.65% |
— |
| ORKA |
Oruka Therapeutics, Inc. |
4.89b |
71.93 |
(2.63%) |
0.00 |
0.00% |
— |
0.00% |
| DFTX |
Definium Therapeutics, Inc. |
4.60b |
32.10 |
(6.30%) |
0.00 |
0.00% |
— |
— |
| DNTH |
Dianthus Therapeutics, Inc. |
4.17b |
72.09 |
(3.27%) |
0.00 |
(10,096.95%) |
(60.77%) |
— |
| EWTX |
Edgewise Therapeutics, Inc. |
4.15b |
37.19 |
(2.64%) |
0.00 |
0.00% |
— |
— |
| ABCL |
AbCellera Biologics Inc. |
4.11b |
11.80 |
(6.94%) |
0.00 |
(248.82%) |
101.29% |
— |
| LEGN |
Legend Biotech Corporation Sponsored ADR |
3.84b |
18.48 |
(6.67%) |
0.00 |
(7.20%) |
59.55% |
— |
| TNGX |
Tango Therapeutics, Inc. |
3.83b |
22.04 |
(2.91%) |
0.00 |
0.00% |
48.29% |
— |
| RLAY |
Relay Therapeutics, Inc. |
3.79b |
16.28 |
(5.90%) |
0.00 |
(2,594.20%) |
(74.29%) |
— |
| ARQT |
Arcutis Biotherapeutics, Inc. |
3.66b |
28.82 |
(0.96%) |
131.00 |
6.15% |
76.11% |
— |
| TLX |
Telix Pharmaceuticals Limited |
3.60b |
10.69 |
1.14% |
— |
— |
— |
— |
| TARS |
Tarsus Pharmaceuticals, Inc. |
3.50b |
68.07 |
(4.11%) |
0.00 |
(7.67%) |
105.17% |
— |
| VKTX |
Viking Therapeutics, Inc. |
3.48b |
25.17 |
(8.04%) |
0.00 |
0.00% |
— |
— |
| ACAD |
ACADIA Pharmaceuticals Inc. |
3.40b |
19.12 |
(2.99%) |
8.50 |
33.42% |
11.75% |
— |
| XENE |
Xenon Pharmaceuticals Inc. |
3.32b |
33.55 |
(2.27%) |
0.00 |
0.00% |
(8.15%) |
— |
| IDYA |
IDEAYA Biosciences, Inc. |
3.27b |
32.85 |
(2.95%) |
0.00 |
(74.75%) |
901.18% |
— |
| CELC |
Celcuity, Inc. |
2.95b |
56.58 |
(6.87%) |
0.00 |
0.00% |
— |
— |
| DNLI |
Denali Therapeutics Inc. |
2.93b |
17.61 |
(4.25%) |
0.00 |
(171.06%) |
194.68% |
— |
| RCUS |
Arcus Biosciences, Inc. |
2.91b |
22.12 |
(3.07%) |
0.00 |
(393.16%) |
(55.34%) |
— |
| ELVN |
Enliven Therapeutics, Inc. |
2.88b |
37.32 |
(5.11%) |
0.00 |
0.00% |
— |
— |
| DYN |
Dyne Therapeutics, Inc. |
2.86b |
14.25 |
(6.80%) |
0.00 |
0.00% |
— |
— |
| NRIX |
Nurix Therapeutics, Inc. |
2.73b |
24.42 |
(2.12%) |
9.74 |
42.01% |
738.76% |
— |
| ZLAB |
Zai Lab Limited Unsponsored ADR |
2.65b |
23.19 |
(1.11%) |
0.00 |
(41.86%) |
5.10% |
— |
| PGEN |
Precigen, Inc. |
2.58b |
6.35 |
(11.81%) |
0.00 |
(392.81%) |
1,875.05% |
— |
| BEAM |
Beam Therapeutics Inc. |
2.55b |
23.47 |
(5.10%) |
0.00 |
(55.45%) |
158.88% |
— |
| NAMS |
NewAmsterdam Pharma Company N.V. |
2.46b |
19.83 |
(3.83%) |
0.00 |
(3,644.21%) |
(88.87%) |
— |
| MBX |
MBX Biosciences, Inc. |
2.44b |
49.61 |
(2.17%) |
0.00 |
0.00% |
— |
— |
| ADMA |
ADMA Biologics Inc |
2.40b |
10.68 |
(0.47%) |
14.83 |
32.98% |
8.04% |
— |
| SLS |
SELLAS Life Sciences Group, Inc. |
2.29b |
9.98 |
(11.99%) |
0.00 |
0.00% |
— |
— |
| CLDX |
Celldex Therapeutics, Inc. |
2.27b |
27.53 |
(4.84%) |
0.00 |
(33,883.77%) |
(88.27%) |
— |
| HRMY |
Harmony Biosciences Holdings, Inc. |
2.23b |
37.95 |
(0.18%) |
12.20 |
18.88% |
24.25% |
— |
| AUPH |
Aurinia Pharmaceuticals Inc |
2.23b |
16.51 |
(1.32%) |
6.91 |
100.84% |
19.76% |
— |
| RXRX |
Recursion Pharmaceuticals, Inc. |
2.23b |
3.47 |
(16.59%) |
0.00 |
(945.92%) |
(15.08%) |
— |
| VRDN |
Viridian Therapeutics, Inc. |
2.22b |
19.03 |
(2.71%) |
0.00 |
(544.06%) |
23,220.33% |
— |
| IRON |
Disc Medicine, Inc. |
2.17b |
56.84 |
0.26% |
0.00 |
0.00% |
— |
— |
| FTRE |
Fortrea Holdings Inc. |
2.16b |
22.49 |
(1.14%) |
0.00 |
(3.18%) |
(2.09%) |
— |
| NVAX |
Novavax, Inc. |
2.11b |
11.26 |
(12.17%) |
0.00 |
(59.87%) |
(61.64%) |
— |
| VCEL |
Vericel Corporation |
2.10b |
40.13 |
(2.17%) |
83.60 |
7.91% |
22.95% |
— |
| PHVS |
Pharvaris N.V. |
2.07b |
27.74 |
(6.14%) |
0.00 |
0.00% |
— |
— |
| VERA |
Vera Therapeutics, Inc. |
2.06b |
27.88 |
(2.42%) |
0.00 |
0.00% |
— |
— |
| IMNM |
Immunome, Inc. |
2.05b |
16.47 |
(5.34%) |
0.00 |
0.00% |
16.74% |
— |
| LKFT |
Lakefront Biotherapeutics - Sponsored ADR |
1.97b |
29.90 |
(0.10%) |
0.00 |
(6.81%) |
(52.22%) |
— |
| AGIO |
Agios Pharmaceuticals, Inc. |
1.93b |
31.32 |
(3.09%) |
0.00 |
(418.24%) |
140.58% |
— |
| MLYS |
Mineralys Therapeutics, Inc. |
1.91b |
20.30 |
(6.19%) |
0.00 |
0.00% |
— |
— |
| SRPT |
Sarepta Therapeutics, Inc. |
1.88b |
17.10 |
(4.10%) |
0.00 |
(6.93%) |
(20.44%) |
— |
| ZYME |
Zymeworks Inc. |
1.84b |
25.07 |
(2.64%) |
0.00 |
(404.00%) |
(69.78%) |
— |
| MRVI |
Maravai LifeSciences Holdings, Inc. |
1.84b |
6.79 |
(3.96%) |
0.00 |
(37.07%) |
(5.03%) |
— |
| PVLA |
Palvella Therapeutics, Inc. |
1.83b |
120.30 |
(5.53%) |
0.00 |
0.00% |
146.67% |
— |
| MESO |
Mesoblast Limited |
1.81b |
13.28 |
(4.80%) |
0.00 |
(1,091.71%) |
(26.54%) |
— |
| URGN |
Urogen Pharma |
1.79b |
34.56 |
(5.60%) |
0.00 |
(51.73%) |
100.27% |
— |